# The Medicines (Marketing Authorisations Etc.) Amendment Regulations 2005, Paragraph 16


In the National Health Service (General Medical Services Contracts) (Wales) Regulations 2004 in paragraph 43 of Schedule 6 (restrictions on prescribing by supplementary prescribers), in sub-paragraph (6), after “human use”, insert “as amended by Directive 2002/98/EC of the European Parliament and of the Council setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components, Commission Directive 2003/63/EC amending Directive 2001/83/EC on the Community code relating to medicinal products for human use, Directive 2004/24/EC of the European Parliament and of the Council amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use and Directive 2004/27/EC of the European Parliament and of the Council amending Directive 2001/83/EC on the Community code relating to medicinal products for human use”.

---
Source: https://www.legislation.gov.uk/uksi/2005/2759/schedule/paragraph/16 (the official version)
Page: https://openlegislation.uk/medicines-marketing-authorisations-etc-amendment-regulations-2005/schedule/paragraph-16
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

